Arrowhead Financial Statements From 2010 to 2022

ARWR
 Stock
  

USD 33.05  0.23  0.69%   

Arrowhead Pharma financial statements provide useful quarterly and yearly information to potential Arrowhead Pharma investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Arrowhead Pharma financial statements helps investors assess Arrowhead Pharma's valuation, profitability, and current liquidity needs.
Arrowhead Pharma does not presently have any fundamental signals for analysis.
.
  
Check Arrowhead Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arrowhead main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Arrowhead financial statements analysis is a perfect complement when working with Arrowhead Pharma Valuation or Volatility modules. It can also supplement Arrowhead Pharma's financial leverage analysis and stock options assessment as well as various Arrowhead Pharma Technical models . Please continue to the analysis of Arrowhead Pharma Correlation against competitors.

Arrowhead Current Liabilities Analysis

Arrowhead Pharma's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Liabilities 
 = 
Payables 
Accrued Debt 
More About Current Liabilities | All Equity Analysis

Current Arrowhead Pharma Current Liabilities

    
  25.64 M  
Most of Arrowhead Pharma's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arrowhead Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Compare to competition

In accordance with the recently published financial statements, Arrowhead Pharma has a Current Liabilities of 25.64 M. This is 98.54% lower than that of the Healthcare sector and 95.28% lower than that of the Biotechnology industry. The current liabilities for all United States stocks is 99.68% higher than that of the company.

Arrowhead Pharma Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Arrowhead Pharma's current stock value. Our valuation model uses many indicators to compare Arrowhead Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Arrowhead Pharma competition to find correlations between indicators driving Arrowhead Pharma's intrinsic value. More Info.
Arrowhead Pharma is number one stock in z score category among related companies. It is the top company in total debt category among related companies making up about  327,494  of Total Debt per Z Score. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Arrowhead Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Arrowhead Pharma's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Arrowhead Pharma's earnings, one of the primary drivers of an investment's value.

About Arrowhead Pharma Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Arrowhead Pharma income statement, its balance sheet, and the statement of cash flows. Arrowhead Pharma investors use historical funamental indicators, such as Arrowhead Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Arrowhead Pharma investors may use each financial statement separately, they are all related. The changes in Arrowhead Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Arrowhead Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Arrowhead Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Arrowhead Pharma. Please read more on our technical analysis and fundamental analysis pages.
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California. Arrowhead Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 329 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Arrowhead Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Arrowhead Pharma's short interest history, or implied volatility extrapolated from Arrowhead Pharma options trading.
Please continue to the analysis of Arrowhead Pharma Correlation against competitors. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for analysis

When running Arrowhead Pharma price analysis, check to measure Arrowhead Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharma is operating at the current time. Most of Arrowhead Pharma's value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arrowhead Pharma's price. Additionally, you may evaluate how the addition of Arrowhead Pharma to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Is Arrowhead Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharma. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arrowhead Pharma is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharma's value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharma's market value can be influenced by many factors that don't directly affect Arrowhead Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Arrowhead Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.